Cargando…
Clinical application of stem cell in patients with end-stage liver disease: progress and challenges
End-stage liver disease (ESLD) is life-threatening disease worldwide, and patients with ESLD should be referred to liver transplantation (LT). However, the use of LT is limited by the lacking liver source, high cost and organ rejection. Thus, other alternative options have been explored. Stem cell t...
Autores principales: | Tao, Ya-Chao, Chen, En-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347777/ https://www.ncbi.nlm.nih.gov/pubmed/32775365 http://dx.doi.org/10.21037/atm.2020.03.153 |
Ejemplares similares
-
The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future
por: Zhang, Sainan, et al.
Publicado: (2020) -
Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint
por: Pareja, Eugenia, et al.
Publicado: (2020) -
The self-renewal dental pulp stem cell microtissues challenged by a toxic dental monomer
por: Kaufman, Gili, et al.
Publicado: (2020) -
Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020) -
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020)